[1] Yanai H. Effects of N-3 polyunsaturated fatty acids on dementia [J]. J Clin Med Res, 2017, 9(1): 1-9.
[2] Poudyal H, Panchal SK, Diwan Ⅴ, et al. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action [J]. Prog Lipid Res, 2011, 50(4): 372-387.
[3] Jacobson TA. Beyond lipids: the role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease [J]. Curr Atheroscler Rep, 2007, 9(2): 145-153.
[4] Pérez J, Ware MA, Chevalier S, et al. Dietary omega-3 fatty acids may be associated with increased neuropathic pain in nerve-injured rats [J]. Anesth Analg, 2005, 101(2): 444-448.
[5] Morishita M, Tanaka T, Shida T, et al. Usefulness of colon targeted DHA and EPA as novel diabetes medications that promote intrinsic GLP-1 secretion [J]. J Control Release, 2008, 132(2): 99-104.
[6] Contrast Ⅰ. The Impact of cholesterol, DHA, and sphingolipids on Alzheimer’s disease [J]. Biomed Res Int, 2013(4): 814390.
[7] Yin Y, Sui C, Meng F, et al. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K/Akt pathway [J]. Lipids Health Dis, 2017, 16(1): 87-95.
[8] Wang F, Bhat K, Doucette M, et al. Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis [J]. Curr Mol Med, 2011, 11(6): 503-511.
[9] Cahill DP, Sloan AE, Nahed BV, et al. The role of neuropathology in the management of patients with diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline [J]. J Neurooncol, 2015, 125(3): 531-549.
[10] Nahed BV, Redjal N, Brat DJ, et al. Management of patients with recurrence of diffuse low grade glioma [J]. J Neurooncol, 2015, 125(3): 609-630.
[11] Ziu M, Olson JJ. Update on the evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: the role of initial chemotherapy [J]. J Neurooncol, 2016, 128(3): 487-489.
[12] Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas [J]. J Neurooncol, 2009, 94(3): 299-312.
[13] Zheng X, Shen G, Yang X, et al. Most C6 cells are cancer stem cells: evidence from clonal and population analyses [J]. Cancer Res, 2007, 67(8): 3691-3697.
[14] Wen PSh, Gao J, Li WH, et al. Expression and significance of arrestin beta 1 in patients with glioma [J]. Acta Anatomica Sinica, 2014, 45(6): 779-784.(in Chinese)
文普帅,高静,李文慧,等. 神经胶质瘤中β-抑制蛋白1的表达及意义[J]. 解剖学报, 2014, 45(6): 779-784.
[15] Cohen GM. Caspases: the executioners of apoptosis [J]. Biochem J, 1997, 326(1): 1-16.
[16] Elmore S. Apoptosis: a review of programmed cell death [J]. Toxicol Pathol, 2007, 35(4): 495-516.
[17] Wu CC, Bratton SB. Regulation of the intrinsic apoptosis pathway by reactive oxygen species [J]. Antioxid Redox Signal, 2013, 19(6): 546-558. |